Article
HBV carrying drug-resistance mutations in chronically infected treatment-naive patients.
Antiviral therapy - 1 Jan 2015
Gomes-Gouvêa Michele S, Ferreira Ariana C, Teixeira Rosangela, Andrade José R, Ferreira Adalgisa S P, Barros Lena M F, Rezende Rosamar E F, Nastri Ana C S Santos, Leite Andrea G B, Piccoli Leonora Z, Galvan Josiane, Conde Simone R S S, Soares Manoel C P, Kliemann Dimas A, Bertolini Dennis A, Kunyoshi Aline S O, Lyra André C, Oikawa Marcio K, de Araújo Luciano V, Carrilho Flair J, Mendes-Corrêa Maria C J, Pinho João R Rebello
Abstract excerpt
BACKGROUND: Nucleoside/nucleotide analogue (NA) treatment causes selection pressure for HBV strains carrying mutations conferring NA resistance. Drug-resistance mutations occur in the reverse transcriptase (RT) region of the HBV polymerase gene and spontaneously arise during viral replication. Th...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
